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Purpose: Modification of a clinical MRI scanner to enable
simultaneous or rapid interleaved acquisition of signals from
two different nuclei.
Methods: A device was developed to modify the local oscillator
signal fed to the receive channel(s) of an MRI console. This ena-
bles external modification of the frequency at which the receiver
is sensitive and rapid switching between different frequencies.
Use of the device was demonstrated with interleaved and simul-
taneous 31P and 1H spectroscopic acquisitions, and with inter-
leaved 31P and 1H imaging.
Results: Signal amplitudes and signal-to-noise ratios were found
to be unchanged for the modified system, compared with data
acquired with the MRI system in the standard configuration.
Conclusion: Interleaved and simultaneous 1H and 31P signal
acquisition was successfully demonstrated with a clinical MRI
scanner, with only minor modification of the RF architecture.
While demonstrated with 31P, the modification is applicable to
any detectable nucleus without further modification, enabling a
wide range of simultaneous and interleaved experiments to be
performed within a clinical setting. Magn Reson Med 76:1636–
1641, 2016. VC 2015 The Authors. Magnetic Resonance in
Medicine published by Wiley Periodicals, Inc. on behalf of
International Society for Magnetic Resonance in Medicine.
This is an open access article under the terms of the Crea-
tive Commons Attribution License, which permits use, dis-
tribution and reproduction in any medium, provided the
original work is properly cited.
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INTRODUCTION
Magnetic resonance imaging and spectroscopy are powerful
tools for investigating human anatomy and physiology in
vivo. While the majority of studies and clinical routine MRI
focus on 1H, other nuclei are also detectable, and all major
hardware manufacturers provide system options to enable
detection of these nuclei using clinical scanners. Nonproton,
or X-nuclear, studies give access to information not available
from proton detection alone. For example, 31P is used to
investigate metabolism via high energy phosphates (1,2), 13C
provides information about glucose and glycogen metabo-
lism (3–5), and 23Na may be used to assess the viability of
healthy and tumorous tissue (6–8) or cartilage defects (9).
Most in vivo multinuclear MR experiments essentially
involve a series of mono-nuclear acquisitions. However,
simultaneous detection of signals from more than one
nuclear species is possible (10–12), offering a reduction in
total measurement time (13,14). In practice, simultaneous
acquisition is difficult because field gradients always act on
both nuclei so that, for example, images acquired simultane-
ously from two different nuclei will have different fields of
view, scaled by the respective gyromagnetic ratios (15). An
alternative approach is to rapidly interleave acquisitions of
two nuclear species (16–18), which offers similar benefit to
simultaneous acquisition but without this intrinsic chal-
lenge. Interleaving also allows one nucleus to be sampled
more frequently than the other (18–20), which is important
for optimal signal-to-noise ratio (SNR) per unit time, given
the potentially very large differences in intrinsic sensitivity
and T1 between
1H and X.
Simultaneous or interleaved acquisition can be
exploited to acquire complementary data from transient
states that are difficult or even impossible to repeat pre-
cisely, e.g., in patients, or when repetition of the experi-
ment affects physiological parameters. For example,
interleaved multinuclear 31P MRS and 1H MRI have been
used to investigate the regulation of oxidative and glyco-
lytic metabolism in skeletal muscle during a single exer-
cise (18,20,21). Recently developed methods for
quantitation of phosphorylated metabolites (22,23) and
pH (24) by 31P MRI and 31P MRS (25) would benefit by
1Center for Medical Physics and Biomedical Engineering, Medical Univer-
sity of Vienna, Austria.
2MR Centre of Excellence, Medical University of Vienna, Austria.
3Laboratory for Functional and Metabolic Imaging, Ecole Polytechnique
Federale de Lausanne, Lausanne, Switzerland.
4Department of Radiology, University of Lausanne, Lausanne, Switzerland.
5Department of Radiology, University of Geneva, Geneva, Switzerland.
zCurrent address: Institute of Neuroscience and Medicine 4, Forschungs-
zentrum J€ulich GmbH, J€ulich, Germany.
Grant sponsor: Austrian Science Fund FWF (to M.M.); Grant numbers:
J3031-N20, I1743-B13; Grant sponsor: Austrian BMWFJ, FFG Project Nr.
832107, “Research Studio for High Field MR Applications” (PI: E.M.); Grant
sponsors: Centre d’Imagerie Biomedicale (CIBM) of the of the Universite de
Lausanne, Universite de Gene`ve, Ho^pitaux Universitaires de Gene`ve,
Centre Hospitalier Universitaire Vaudois and Ecole Polytechnique Federale
de Lausanne and Leenaards and Jeantet Foundations.
*Correspondence to: Dr. Martin Meyerspeer, PhD; Center for Medical
Physics and Biomedical Engineering, Medical University of Vienna, Austria.
E-mail: martin.meyerspeer@meduniwien.ac.at
yThe first authorship is shared between Meyerspeer and Magill.
Received 13 September 2015; revised 16 October 2015; accepted 25
October 2015
DOI 10.1002/mrm.26056
Published online 26 November 2015 in Wiley Online Library
(wileyonlinelibrary.com).
VC 2015 The Authors. Magnetic Resonance in Medicine published by Wiley
Periodicals, Inc. on behalf of International Society for Magnetic Resonance
in Medicine. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.
Magnetic Resonance in Medicine 76:1636–1641 (2016)
VC 2015 The Authors. Magnetic Resonance in Medicine published by
Wiley Periodicals, Inc. on behalf of International Society for
Magnetic Resonance in Medicine
1636
combination with interleaved measurements of perfusion
and blood oxygenation by 1H MRI (26). Further, coregis-
tration problems between 1H and X-nuclear data sets
could be alleviated and promising applications, such as
dynamic shimming or 1H-based motion correction of X-
nuclear data (12), require interleaved acquisition of 1H
imaging data. However, most of these prior works on
multinuclear simultaneous and interleaved detection
have been accomplished on research systems or with sig-
nificant modification to the spectrometer.
To run simultaneous or interleaved dual-nuclear experi-
ments, the MRI system must be capable of exciting the sam-
ple, and recording the resulting NMR signals, at the two
different frequencies. Transmit pulses must be generated
simultaneously or in quick succession. Most multinuclear-
capable MRI systems already have this capability, intended
to be used for nuclear Overhauser enhancement (nOe),
polarization transfer, and J-decoupling. Also, the RF probe
must be simultaneously tuned to both frequencies of inter-
est. A standard dual-resonant probe (27–29) may be used
here, including those commercially available. Finally, the
MRI console must be able to process and digitize signals at
two different frequencies or, for interleaved acquisition, rap-
idly switch between two different acquisition frequencies. It
is this last part that is generally not possible using a standard
clinical MRI scanner, and that we address in this work.
METHODS
Functional Principle
MR signals can occur over a wide range of frequencies,
typically on the order of tens to hundreds of megahertz.
Rather than digitizing NMR signals directly at the Lar-
mor frequency, most MRI spectrometers use the superhe-
terodyne principle to first convert the signal down to a
lower frequency of the order of a few megahertz (30).
This is done by mixing the received signal with a refer-
ence signal, called the local oscillator (LO), to produce
an output at the frequency difference between the origi-
nal signal and the LO, known as the intermediate fre-
quency (IF). By adjusting the LO, which is generated by
the system synthesizer, the IF can always be set to a
fixed frequency, independent of the frequency of the
NMR signal. The signal is then directly digitized at the
IF by the analogue-to-digital converter (ADC).
By externally modifying the LO, the frequency at
which the spectrometer is sensitive can be manipulated.
This is the principle behind the operation of the inter-
leaving device, built to our specification by Pure Devices
(W€urzburg, Germany), shown schematically in Figure 1.
It is inserted into the system receive chain between the
synthesizer and the receivers. By default, the interleav-
ing device rests in the passive state, passing the system
LO from input to output. All system adjustments and
mononuclear experiments can be performed in the nor-
mal manner when the interleaving device is in this state.
The device is activated by a digital control signal pro-
vided by the MRI console and controlled via the pulse
sequence. Once active, the interleaving device replaces
the system LO with a signal generated by an auxiliary
synthesizer. This synthesizer has a frequency resolution
of 1 kHz and is synchronized to the MRI scanner via a
console-provided 10 MHz reference signal to ensure fre-
quency and phase stability relative to the console. The
frequency of the auxiliary synthesizer is set using an
external computer via a Universal Serial Bus (USB) con-
nection. When the interleaving device is active, the fre-
quency of the signal digitized by the scanner is
determined by the auxiliary synthesizer, rather than the
console.
The frequency synthesizer of the MRI console used in
this work has a resolution of 2.5 MHz, limiting how
accurately the LO can be offset from the Larmor fre-
quency, resulting in different IFs for different nuclei.
The ADC and RF stage following the mixer have a much
wider bandwidth than the MR signal. Provided that the
IF offset plus the bandwidth of the MR signal fits inside
this wider bandwidth, the signal may be recorded at full
fidelity. The frequency offset is then removed in digital
postprocessing. The offset frequency used in this digital
stage is not user-configurable, so the frequency of the
auxiliary synthesizer must be set to reproduce the IF of
the nuclei that the console is configured to detect. For
example, to digitize a 31P signal at 7 T (f0¼ 120.32 MHz),
the console provides a LO at 122.50 MHz to give an IF of
2.18 MHz. To record a 1H signal (f0¼297.22 MHz), the
interleaving device LO must be set to 299.41 MHz to
reproduce the same IF. The receive bandwidth of the
final signal is controlled per ADC event via the dwell
time as a pulse sequence parameter and can be selected
independently for each nucleus.
The receive channels of the MRI system used in this
work are grouped into four banks of eight channels, each
bank having a separate LO input. For interleaved acqui-
sition, the frequency of any or all banks of receive chan-
nels can be switched. For simultaneous acquisition at
two frequencies, at least one bank must continue to oper-
ate unchanged.
The interleaving device only modifies the receive
chain of the scanner. The RF coil and its interface to the
scanner require no customization. Any coil capable of X
FIG. 1. Schematic diagram showing the RF pathway modification.
The interleaving device is inserted between the system synthe-
sizer and LO input of the receiver. In passive mode, the system
LO is passed through the interleaving device, while in active
mode, a replacement LO signal is generated by the auxiliary syn-
thesizer, which is fed to the receiver in place of the system LO.
The interleaving device is switched between passive and active
mode via a control signal generated by the scanner and controlled
via the pulse sequence.
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and 1H acquisition is suitable for interleaved acquisition,
and any coil capable of heteronuclear decoupling can be
used for simultaneous acquisition. The MRI console is
already capable of generating transmit pulses at the Lar-
mor frequency and at a second “decoupler” frequency,
within a single pulse sequence. This feature is intended
for nOe and J-decoupling, but can be used to generate
excitation pulses for a second nuclear species.
The safety-critical transmit chain is not modified in
any way, so the scanner RF safety system, including
SAR monitoring, continues to operate in the normal
manner. The interleaving device, therefore, has no
impact on system safety or safety monitoring.
MR Experiments
To evaluate the function and performance of the inter-
leaving device, spectroscopy and imaging experiments
were conducted on a Siemens Magnetom 7 T (Siemens
Medical, Erlangen, Germany). All experiments on the 7
T system were performed using an in-house built RF
probe, consisting of two 1H and three 31P transceive ele-
ments, shaped to a half cylinder (d¼ 14 cm, l¼10 cm)
(29). The test object was a spherical phantom containing
500 mL aqueous phosphate solution (K2HPO4, 100
mmol/L). Functionality was also tested on a Siemens
Tim Trio, a 3 T MRI system equipped with a concentric
31P/1H single loop coil (d¼10 cm, Rapid Biomedical,
W€urzburg, Germany).
To examine the interleaving device’s influence on SNR
and signal amplitude in NMR experiments as directly as
possible, several series of pulse-acquire 1H and 31P spectra
were compared. 1H-only and 31P-only measurements were
conducted without the interleaving device present, and
with the interleaving device connected but passive (i.e.,
passing the system LO to the receivers). Interleaved and
simultaneous multinuclear acquisitions were then made
using the interleaving device with the sequences shown in
Figure 2a and b. The interleaving device is only active dur-
ing 1H reception. For simultaneous multinuclear acquisi-
tion, the LO fed to the receivers recording the 1H signal is
modified by the interleaving device, while the receivers
recording the 31P signal use the system LO unmodified. As
the MRI console is not able to generate simultaneous RF
pulses at two different frequencies, fast sequential excitation
of both nuclei was used (31), as shown in Figure 2b. To elim-
inate the influence of nOe (18), experiments were repeated
with the 1H transmit pulse amplitude set to zero for 31P data
quantification.
Because both the system and the auxiliary LO are run-
ning phase continuously, a constant phase will be accu-
mulated in every consecutive acquisition of data (i.e.,
each k-space line or averaging step, spaced by TR) that
are subject to mixing with the interleaving device’s LO.
This phase accrual can be accounted for by prospectively
incrementing the phase of the 1H acquisition by
Dw ¼ ðf1H  fXÞ  TR; [1]
where f1H and fX are the respective Larmor frequencies
and TR is the repetition time.
For reproducible SNR quantification, 50 spectra were
acquired in each state (2048 complex points, 5000 Hz
spectral bandwidth), using a repetition time of 2 s. SNR
was quantified in the frequency domain as peak ampli-
tude divided by the standard deviation of data points
from an artefact-free flat baseline region of the spectra.
For 1H free induction decays, small nutations were used
(0.1 near the coil), resulting in a constant signal
amplitude throughout each measurement series and a
flat spectral baseline. Phosphorous free induction
decays, with inherently lower SNR, were excited with
higher flip angles (70). The first 10 spectra were
excluded from each dataset to ensure that the system
had reached steady-state.
Images were also acquired to demonstrate use of the
interleaving device with a more complicated acquisition
sequence involving faster frequency switching and the use
of field gradients. A 3D gradient-echo sequence was modi-
fied to alternately acquire k-space lines for each nucleus
(Fig. 2c). The echo time and effective repetition time for
FIG. 2. Pulse-acquire sequences, for (a) interleaved and (b) simul-
taneous acquisition of 1H and 31P spectra; (c) shows a 3D
gradient-echo imaging sequence, which alternately acquires k-
space lines for 1H and 31P.
1638 Meyerspeer et al.
each nucleus was TE¼ 3.8 ms and TR¼ 16 ms. Equal gra-
dient amplitudes were used for both nuclei, resulting in
2.47 times (g1H=g31P) larger voxels and field of view for
the 31P images than for 1H images, helping to compensate
for the lower sensitivity and abundance of 31P. The nomi-
nal voxel size was 3:1 3:1 12:4 mm3 for the 31P images
and 1:25 1:25 5 mm3 for the 1H images, with the same
matrix size of 128 128 24 for both nuclei. Four aver-
ages were acquired in interleaved and 31P-only scans,
leading to a total measurement time of 3 min 17 s. For 1H
MRI, unaveraged data are shown. Images were recon-
structed offline using software written in-house in the
Perl Data Language (PDL, http://pdl.perl.org).
RESULTS
NMR data were successfully collected with interleaved
and simultaneous multinuclear acquisitions on a
Magnetom 7 T and a Tim Trio 3 T system. No adverse
effects of the interleaving device on signal amplitude,
SNR or phase stability were found. The switching time
of the interleaving device, measured using an oscillo-
scope (TDS 3052, Tektronix, Beaverton, OR), was found
to be within 10 ms of the control signal changing state.
The results of the performance tests using pulse-
acquire experiments at 7 T are shown in Figure 3. Mea-
surement precision was better than 61% for the signal
amplitude for both nuclei, approximately 66% for 31P
SNR, and 63% for 1H SNR. Looping the system LO
through the interleaving device in the passive state made
no measurable difference to SNR or signal intensity in
free induction decays obtained for either nucleus. For
simultaneous and interleaved 31P/1H acquisitions, an
nOe-induced increase of 31P signal and SNR on the order
of 10% was observed when 1H magnetization was
excited (18). SNRs obtained for 31P during interleaved
and simultaneous measurements without 1H excitation
were identical to those measured in mononuclear experi-
ments without the interleaving device connected, to
within measurement precision, while the differences in
signal amplitudes were below 1%. Exciting 31P magnet-
ization produced no measurable nOe in 1H spectra. Spec-
tra used to quantify 1H signal intensity and SNR in
simultaneous and interleaved acquisitions were meas-
ured in the presence of 31P excitation and showed no
change in signal intensity or SNR when compared with
mononuclear acquisitions made without the interleaving
device present. In summary, the interleaving device did
not affect the SNR or amplitude of 31P or 1H signals in
any of the above measurements.
Images acquired at 7 T are shown in Figure 4. No dif-
ference is seen between 1H images acquired with and
without interleaving. An increase in signal intensity is
seen in the 31P image with interleaving, relative to the
image without, due to nOe from the 1H pulses. It was
verified that the larger 31P FOV in interleaved acquisi-
tions did not have an effect on SNR, 31P images were
also acquired with the same voxel size but with a
reduced matrix size of 52 52 10, corresponding to the
same FOV as 1H images. The number of averages was
increased to 24, for comparable total measurement time
(3 min 20 s).
A constant phase accrual was found between consecu-
tive TR steps in
1H data. The phase increment between
30 free induction decays acquired in a single scan was
linearly TR-dependent (R
2  0:9999) and could be cor-
rected by introducing an incremental offset to the
receiver phase for 1H acquisitions using Eq. [1]. 31P data,
acquired using the system LO routed via the interleaving
device, showed no phase drift.
DISCUSSION AND CONCLUSION
In this work, we have demonstrated a simple hardware
modification to a clinical MRI scanner that enables inter-
leaved and simultaneous acquisition of signals from two
different nuclei. Using 31P and 1H, signal amplitudes
FIG. 3. Signal-to-noise ratio and signal amplitude of (a) 31P and
(b) 1H pulse-acquire experiments using a test object. Perform-
ance with the scanner in the standard configuration was not
degraded when the interleaving device was added in passive
mode, and when it was used to enable interleaved or simultane-
ous acquisitions. Note that the interleaving device is only ever
active during 1H acquisitions. For interleaved acquisitions, the
device is always passive during 31P readout, while for simultane-
ous acquisitions 31P is measured on a receive bank not con-
nected to the device.
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and signal-to-noise ratios quantified in spectra and
images acquired using the interleaving device were
found to be indistinguishable from data acquired in sep-
arate, mononuclear acquisitions with the system in its
standard configuration.
While the device was demonstrated using 31P and 1H,
the presented method can be used to combine acquisi-
tions of any pair of nuclei the host system is able to
excite. The interleaving device has many possible appli-
cations, such as 31P or 13C spectroscopy concurrent with
1H spectroscopy or imaging, simultaneous 23Na/1H imag-
ing, combined 31P/1H spectroscopic imaging or the use
of 1H navigators for nonproton MRI. Decoupling at the
Larmor frequency of one of the interleaved nuclei can be
applied during the readout of the other nucleus (e.g.,
during an interleaved 13C/1H acquisition, 1H decoupling
of the 13C readout is possible). However, this effectively
reduces the TR at the decoupling frequency, which will
impact the SNR efficiency for that nucleus. Developing
pulse sequences that integrate excitation and readout of
signal from two different nuclei is potentially compli-
cated, but the only modification required to use the
interleaving device is the addition of a continuous con-
trol signal for the duration of the frequency-shifted
acquisition. Most MRI consoles provide such user-
programmable control signals, generally used for trigger-
ing and system debugging.
The modification presented here can be applied to any
system using superheterodyne receivers where the LO is
accessible, where the console allows transmission of RF
pulses at different frequencies during a single pulse
sequence (as is usually possible on systems equipped
with X-nuclear capabilities for decoupling and nOe), and
that provides a digital control signal that can be used to
activate the interleaving device during reception.
The method we present here is very similar to the
approach recently presented by Jeong and Kaggie (32,33).
Their method introduces an extra mixer, used to shift
the frequency of the interleaved 1H signal down to the X
frequency, which the scanner then records as if it was an
X signal. This adds an extra component to the RF chain,
which may have some impact on system SNR, but allows
all system modifications to be made between the RF coil
and the receive plug of the scanner. Our approach is
simpler, in that only the receiver LO is modified, with
all mixing done by the standard system components in
the normal manner. As no additional components are
inserted into the receive chain, the impact on SNR is
negligible. An advantage of the method presented here is
its inherent array coil capability, as all channels of a
receiver bank (eight in case of the MRI system used here)
are controlled with a single device.
In summary, the device presented in this work enables
simultaneous and rapidly interleaved acquisition of sig-
nals from two different nuclei, without loss of signal
intensity or SNR for either nucleus. The interleaving
device is the technical prerequisite for the combining
dual-nuclear imaging and spectroscopy techniques into
one sequence, which had been impossible on many clin-
ical platforms, thus opening up exciting possibilities for
future research and potential clinical application.
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FIG. 4. 1H (a, c) and 31P (b, d) images
acquired with (a, b) and without (c, d)
interleaving. Images in the top row were
acquired in a single experiment. Images in
the bottom row were acquired in two sep-
arate experiments, using the same
sequence, but with transmission at the
unused frequency omitted, to demonstrate
the effect of nOe. 31P images were
cropped to have the same FOV as 1H
images. The increased brightness of (b)
relative to (d) can be ascribed to nOe from
the 1H excitation pulses.
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